ID: ALA5200257

Max Phase: Preclinical

Molecular Formula: C29H36ClN5O7S

Molecular Weight: 634.16

Associated Items:

Representations

Canonical SMILES:  CC(C)C(NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)c1ccc(C(=O)NS(=O)(=O)c2ccc(Cl)cc2)cc1)C(C)C)C(N)=O

Standard InChI:  InChI=1S/C29H36ClN5O7S/c1-16(2)23(25(31)36)32-28(39)22-6-5-15-35(22)29(40)24(17(3)4)33-26(37)18-7-9-19(10-8-18)27(38)34-43(41,42)21-13-11-20(30)12-14-21/h7-14,16-17,22-24H,5-6,15H2,1-4H3,(H2,31,36)(H,32,39)(H,33,37)(H,34,38)/t22-,23?,24-/m0/s1

Standard InChI Key:  OIDVQJPRFNQTHN-OTKIHZFJSA-N

Associated Targets(Human)

Leukocyte elastase 8173 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 634.16Molecular Weight (Monoisotopic): 633.2024AlogP: 1.83#Rotatable Bonds: 11
Polar Surface Area: 184.84Molecular Species: ACIDHBA: 7HBD: 4
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.28CX Basic pKa: CX LogP: 2.31CX LogD: 1.37
Aromatic Rings: 2Heavy Atoms: 43QED Weighted: 0.29Np Likeness Score: -0.90

References

1. Zhang Y, Pike A..  (2021)  Pyridones in drug discovery: Recent advances.,  38  [PMID:33609656] [10.1016/j.bmcl.2021.127849]

Source